Annual Reports in Medicinal Chemistry

Inbunden, Engelska, 2026

Del 67 i serien Annual Reports in Medicinal Chemistry

2 177 kr

Kommande

Beskrivning

Annual Reports in Medicinal Chemistry, Volume 67 presents authoritative and forward-looking reviews that capture current advances in medicinal chemistry, with a strong emphasis on molecular conjugates, hybrid therapeutics, and precision drug design. Contributions from leading international researchers examine emerging strategies for antiviral, antifungal, and antimicrobial drug development, including small-molecule conjugates, aptamer-RNA platforms, terpene-derived hybrids, and intracellular targeting approaches.

The volume highlights how chemical innovation is being leveraged to address drug resistance, emerging viral threats, and unmet clinical needs, while also reflecting broader methodological advances in conjugate design, carrier systems, and structure-activity relationships. As with previous volumes in the series, ARMC 67 serves as both a critical reference and a forward-looking guide for medicinal chemists in academia and industry.

Authoritative reviews by internationally recognised experts in medicinal and pharmaceutical chemistry
Strong focus on drug conjugates, hybrid molecules, and precision therapeutics
Coverage of antiviral, antifungal, and antimicrobial strategies addressing emerging and resistant pathogens
Emphasis on design principles, synthesis, and structure-activity relationships
Balances fundamental chemical insight with translational and therapeutic relevance
Essential reference for researchers, graduate students, and professionals in drug discovery and development

Produktinformation

Utgivningsdatum:2026-11-01
Mått:152 x 229 x undefined mm
Format:Inbunden
Språk:Engelska
Serie:Annual Reports in Medicinal Chemistry
Antal sidor:310
Förlag:Elsevier Science
ISBN:9780443472626

Utforska kategorier

Farmakologi inom Medicin
Kemi inom Naturvetenskap och teknik
Organisk kemi inom Naturvetenskap och teknik

Mer om författaren

Prof. Katherine Seley-Radtke group’s NIH-funded research employs a chemical biology approach tonucleoside, nucleotide and heterocyclic drug discovery and development with therapeuticemphasis on antiviral, anticancer and antiparasitic targets and overcoming resistance to currentlyused drugs. Current focus is targeting Ebola, Zika, Dengue and MERS viruses. She has served asthe Program Director for UMBC’s Chemistry-Biology Interface graduate training programfunded by NIH since 2007. This program promotes hands on cross disciplinary research foralmost 50 PhD students from four departments at UMBC and UMB. She is currently theImmediate Past President and Secretary-Elect for the International Society of Nucleosides,Nucleotides and Nucleic Acids and a Board member of the International Society for AntiviralResearch. Prof. Seley-Radtke also serves as a standing member for several NIH study sectionsand is an Associate Editor for three scientific journals – Antiviral Chemistry & Chemotherapy,Molecules – Chemical Biology, and Current Protocols in Chemical Biology.